Author: Spark Biomedical

Posted Date:

May 4, 2026

Spark Biomedical Appoints Anja Krammer as Chief Executive Officer to Accelerate Clinical and Commercial Growth

Spark Biomedical

May 4, 2026
Two Medtech Industry Leaders Selected to Serve on NIH HEAL Initiative® Multi-Disciplinary Working Group

Spark Biomedical

May 3, 2026
New Wearable Technology Shows Clinically Meaningful Reductions in Heavy Menstrual Bleeding

Spark Biomedical

May 2, 2026
Spark Biomedical Launches Pivotal Phase II LUNA Trial for Heavy Menstrual Bleeding

Spark Biomedical

March 10, 2026
UT Southwestern and UTMB Awarded $500,000 TRC4 Grant to Study Non-Invasive Neurostimulation for Chronic Subdural Hematomas

Spark Biomedical

February 16, 2026